Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant liver tumors.

Arief A Suriawinata1, Swan N Thung

  • 1Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, USA.

Clinics in Liver Disease
|July 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mesenchymal Tumors of the Liver: An Update Review.

Biomedicines·2025
Same author

Shared Features of Obliterative Portal Venopathy, Normal Liver, and Chronic Liver Disease: A Histologic and Morphometric Analysis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025
Same author

Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC.

JHEP reports : innovation in hepatology·2024
Same author

Pathology and diagnostic approaches to well-differentiated hepatocellular lesions: a narrative review.

Journal of Yeungnam medical science·2024
Same author

Masked pre-training of transformers for histology image analysis.

Journal of pathology informatics·2024
Same author

Mechanisms of Sorafenib Resistance in HCC Culture Relate to the Impaired Membrane Expression of Organic Cation Transporter 1 (OCT1).

Journal of hepatocellular carcinoma·2024
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Primary malignant liver tumors originate from various liver cells. Definitive diagnosis relies on biopsy, though imaging and clinical factors like age aid in identifying specific tumor types.

Area of Science:

  • Hepatology
  • Oncology
  • Pathology

Background:

  • Primary malignant liver tumors originate from diverse hepatic cell types, including hepatocytes and bile duct epithelium.
  • Accurate diagnosis is crucial for effective treatment strategies.
  • Patient demographics, such as age, significantly influence the likelihood of specific liver tumor types.

Purpose of the Study:

  • To summarize the origins and diagnostic approaches for primary malignant liver tumors.
  • To highlight the importance of integrating imaging, clinical history, and biopsy for accurate diagnosis.
  • To emphasize age as a key factor in differentiating pediatric from adult liver tumors.

Main Methods:

  • Review of primary malignant liver tumor origins.
  • Analysis of diagnostic modalities including imaging and biopsy.

Related Experiment Videos

  • Correlation of tumor types with patient age and clinical history.

    • Main Results:

    • Liver tumors can arise from hepatocytes, bile duct epithelium, neuroendocrine cells, and mesenchymal cells.
    • Imaging studies suggest diagnoses, but biopsy confirms them.
    • Age is a critical factor, with certain tumors (e.g., hepatoblastoma) prevalent in children and others (e.g., hepatocellular carcinoma) in adults.

    Conclusions:

    • A comprehensive diagnostic approach combining imaging, clinical context, and biopsy is essential for primary malignant liver tumors.
    • Understanding the age-specific incidence of liver tumors aids in differential diagnosis.
    • Early and accurate diagnosis impacts patient outcomes.